Fortis Life Sciences in the news

Fortis Life Sciences acquires nanoComposix

July 23, 2021

Fortis Life Sciences has completed its acquisition of nanoComposix, a premiere nanomaterials company focused on solutions for assay development and diagnostics.  Since 2004, nanoComposix has built one of the most comprehensive nanomaterials portfolios in the industry.  nanoComposix’s nanomaterials are used in a wide array of Life Sciences applications, including drug delivery, diagnostics and imaging, as well as industrial applications.

Read more on the nanoComposix website

Fortis Life Sciences Acquires Bethyl Laboratories

March 10, 2021

Fortis Life Sciences, a life sciences company offering products and solutions for the life sciences industry, has acquired the premium antibody company Bethyl Laboratories. Based in Montgomery, Texas, Bethyl Laboratories has a long history of offering the highest quality primary and secondary antibodies to its customers, as well as other protein detection reagents. Bethyl Laboratories is well known for industry leading performance and the highest standards in antibody validation, and prior to the acquisition by Fortis, had successfully operated as a private, family-owned, and operated business for nearly 50 years.

Read more on the Bethyl Laboratories website